Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life
scientific article
Author/s
author: Chitra Hosing, Rima M Saliba, Richard E Champlin, Gabriela Rondon, Sergio Giralt, Yago Nieto, Muzaffar Qazilbash, Matteo Pelosini, Alexandre Chiattone, Partow Kebriaei, Leandro de Padua Silva, Gheath Alatrash
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.